Long-term remission of a Her2/neu positive primary breast cancer under double monoclonal antibody therapy with trastuzumab and bevacizumab. [electronic resource]
Producer: 20140703Description: 184-8 p. digitalISSN:- 1318-2099
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.